Form 4: SpringWorks Therapeutics Director Carlos Alban Receives Equity Grants

Director Carlos Alban received restricted stock units and stock options from SpringWorks Therapeutics as part of the company's non-employee director compensation policy.

Summary

• Carlos Alban, a director at SpringWorks Therapeutics, received 4,095 restricted stock units (RSUs) and options to purchase 12,216 shares of common stock on May 16, 2024.
• The grants were made under the company's Amended and Restated Non-Employee Director Compensation Policy.
• The RSUs vest on the earlier of May 16, 2025, or the date of the next annual meeting of stockholders, contingent upon continued service.
• The stock options have an exercise price of $44.77 and also vest on the earlier of May 16, 2025, or the date of the next annual meeting of stockholders, contingent upon continued service.

Sentiment

Score: 7

Explanation: The document reflects a routine equity grant to a director, which is generally viewed as a positive sign of alignment between management and shareholders. The terms are standard, and there are no red flags.

Positives

• The equity grants align the director's interests with those of the shareholders.
• The vesting schedule incentivizes continued service to the company.

Future Outlook

The director's continued service is tied to the vesting of the equity grants, suggesting an expectation of ongoing involvement with the company.

Industry Context

Equity grants are a common form of compensation for non-employee directors, aligning their interests with the long-term performance of the company. The specific terms of the grant, such as the vesting schedule, are typical for director compensation packages.

Comparison to Industry Standards

• Director compensation packages often include a mix of cash and equity.
• The vesting schedule of one year is fairly standard for director equity grants.
• The size of the grant would need to be compared to peer companies to determine if it is above or below average.

Stakeholder Impact

• Shareholders: The equity grants align the director's interests with those of the shareholders.
• Director: The director receives additional compensation in the form of equity.

Key Dates